See more : PT Eratex Djaja Tbk (ERTX.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Peoplesway.com Inc. (PLWY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Peoplesway.com Inc., a leading company in the Specialty Retail industry within the Consumer Cyclical sector.
- Tainwala Chemicals and Plastics (India) Limited (TAINWALCHM.BO) Income Statement Analysis – Financial Results
- Sunstock, Inc. (SSOK) Income Statement Analysis – Financial Results
- Larkspur Health Acquisition Corp. (LSPRU) Income Statement Analysis – Financial Results
- Bombardier Inc. (BBD-B.TO) Income Statement Analysis – Financial Results
- GTL Infrastructure Limited (GTLINFRA.NS) Income Statement Analysis – Financial Results
Peoplesway.com Inc. (PLWY)
About Peoplesway.com Inc.
Peoplesway.com Inc. develops and sells wellness products. It offers weight management, pain relief, skincare, and bio-identical hormone replacement products, as well as supplements. The company provides Pro-HM, a solution for hormonal imbalances in women; Pro-MC, a hormonal product for men; ProTec, an antioxidant supplement for protection against free radicals that destroy cells; and ProTrim, a dietary supplement. It also offers Oil of Mink that prevent fine lines and wrinkles in men and women; and Pro-GCM Plus and Pro-GCM, which are joint protection products. The company also sells its products online. Peoplesway.com Inc. was founded in 1980 and is headquartered in Charlotte, North Carolina.
| Metric | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|
| Revenue | 1.18M | 617.07K | 1.03M | 408.40K |
| Cost of Revenue | 571.38K | 239.51K | 426.38K | 214.83K |
| Gross Profit | 607.07K | 377.56K | 602.69K | 193.56K |
| Gross Profit Ratio | 51.51% | 61.19% | 58.57% | 47.40% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 886.56K | 426.77K | 476.11K | 266.58K |
| Selling & Marketing | 7.80K | 2.10K | 1.12K | 1.14K |
| SG&A | 894.36K | 428.87K | 477.23K | 267.72K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 897.62K | 432.13K | 480.35K | 267.72K |
| Cost & Expenses | 1.47M | 671.64K | 906.74K | 482.55K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 18.98K | 49.25K | 0.00 |
| Depreciation & Amortization | 3.26K | 3.26K | 3.13K | -148.32K |
| EBITDA | -287.29K | -287.29K | -143.73K | -113.99K |
| EBITDA Ratio | -24.38% | -8.31% | 35.46% | 4.46% |
| Operating Income | 290.55K | 54.57K | 117.11K | 166.51K |
| Operating Income Ratio | 24.66% | 8.84% | 11.38% | 40.77% |
| Total Other Income/Expenses | 0.00 | -360.54K | -239.45K | -92.36K |
| Income Before Tax | 0.00 | 0.00 | -122.34K | 74.16K |
| Income Before Tax Ratio | 0.00% | 0.00% | -11.89% | 18.16% |
| Income Tax Expense | 15.41K | 18.98K | 288.70K | 240.67K |
| Net Income | -305.96K | -73.56K | -166.36K | -166.51K |
| Net Income Ratio | -25.96% | -11.92% | -16.17% | -40.77% |
| EPS | -0.02 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.02 | -0.01 | -0.01 | -0.02 |
| Weighted Avg Shares Out | 14.41M | 13.09M | 14.94M | 9.72M |
| Weighted Avg Shares Out (Dil) | 14.41M | 13.09M | 14.94M | 9.72M |
Source: https://incomestatements.info
Category: Stock Reports